NAGA antibody (AA 43-329) (APC)
Quick Overview for NAGA antibody (AA 43-329) (APC) (ABIN8012970)
Target
See all NAGA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 43-329
-
Purpose
- Anti-NAGA Antibody APC Conjugated
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins
-
Predicted Reactivity
- Human NAGAshares 86.7%,85.4% amino acid (aa) sequence identity with mouse,rat NAGA,respectively.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human NAGA recombinant protein (Position: D43-R329). Human NAGAshares 86.7% and 85.4% amino acid (aa) sequence identity with mouse and rat NAGA, respectively.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Expiry Date
- 12 months
-
-
- NAGA (N-Acetylgalactosaminidase, alpha (NAGA))
-
Alternative Name
- NAGA
-
Background
-
Background: NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease).
Gene Full Name: alpha-N-acetylgalactosaminidase
-
Gene ID
- 4668
-
UniProt
- P17050
Target
-